Today we celebrate the inauguration of the Leukemia Unit Centro Comprensivo de Cancer UPR a 24 bed unit for patients with hematologic malignancies in #PuertoRico This is a big step for the government of Puerto Rico, and the Ciencias Médicas UPR Departamento de Salud de Puerto Rico Puerto Rico Science, Technology & Research Trust Financial Oversight & Mgmt Board for Puerto Rico and marks the beginning of a new era

Enjoying a day with my mother💕. Happy Mother’s Day to all wonderful professional mothers, who balance family and work life and as they do, the world is a better place💐 #MotherDay

Celebrating the 2024 AACR Cancer Disparities Progress Report in the US Congressional Briefing Congress with Margaret Foti, PhD, MD (hc) @NCICRCHD FDA Oncology Dr. Marge Foti, Dr. Rob Winn, Dr. Sanya Springfield and Michelle Torres, daughter of Anibal Torres #hcc survivor PanOncology Trials

Watch “Anibal Torres: AACR Cancer Disparities Progress Report 2024” on #Vimeo vimeo.com/936341568?ref=…

“Quiero vivir”: destacan la lucha contra el cáncer del puertorriqueño Aníbal Torres en un estudio presentado en el Congreso - via @elnuevodia elnuevodia.com/corresponsalia…

Celebrating the NCI Gastric Cancer Task Force led by Dr. Constanza Camargo, ⁦National Cancer Institute⁩, thank you!! Over 150 scientists from around the world discussed research gaps and strategies #GastricCancer screening, prevention, interception! ⁦PanOncology Trials⁩ ⁦⁦AACR⁩

Visiting Orlando Health Digestive Health & Orlando Health Cancer Institute Extraordinary clinicians educators and investigators, passionate about quality, and exceptional cancer care. Looking forward to collaborating and sharing best practices 🙌🇵🇷🧡 PanOncology Trials

FDA approves #ADAGRASIB for patients with advanced #ColorectalCancer with #KRAS mutated tumors. Increase in survival was witness by our ⁦PanOncology Trials⁩ #clinicaltrials team providing access to patients in #PuertoRico 🇵🇷⁦FDA Oncology⁩ 💪🧡 news.bms.com/news/corporate…

Exciting opportunity to participate on a clinical trial evaluating GLP1 agonist (Efinopegdutide) for patients with fatty liver disease of >10% of Fat using MRI-PDFF Participants will receive study medication as part of the study🙌 #fattyliver #NASH ⁦PanOncology Trials⁩

Celebrating the life of Dr. Antonio Puras, Chair of Urology ⁦Ciencias Médicas UPR⁩ who lead an extraordinary academic program. We witnessed your passion, dedication to your residents, family, friends, & your love for Culebra! Your legacy will leave forever, we will never forget you❤️

GLP-1RAs were found to decrease Obesity-Associated Cancers in Patients with Diabetes, including decreased risk of #colorectal and #pancreas cancers jamanetwork.com/journals/jaman…

Very honored to have been included in this extraordinary group of professional women in Puerto Rico🇵🇷 Thank you L’Oreal Celebran la aportación de 45 mujeres líderes - via @elnuevodia elnuevodia.com/magacin/inspir…

The data on GLP1 agonists continues to demonstrate improvements in liver fibrosis and steatosis among those using Tirzeletide vs placebo. Patients with & without DM lost weight and had a significant decrease in liver fibrosis. Our group PanOncology Trials is evaluating similar GLP1/2

What an honor to participate as keynote speaker in the Multiple Myeloma Research in the 3rd Foundation Health Equity Summit in DC!! 🧡 Much progress has been done in the development of targeted medications and in the life expectancy of patients with #MultipleMyeloma but access